# Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy

> **NCT05951699** · — · UNKNOWN · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 105 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** minimally invasive preoperative image-guided vacuum-assisted biopsy

## Key facts

- **NCT ID:** NCT05951699
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-28
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05951699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05951699, "Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05951699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*